Axsome Therapeutics Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
/ 
Frequently asked questions
To buy Axsome Therapeutics Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Axsome Therapeutics Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Axsome Therapeutics Inc. is AXSM:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Axsome Therapeutics Inc. has its primary listing on NASDAQ (Small cap). You can trade Axsome Therapeutics Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Axsome Therapeutics Inc. is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Axsome Therapeutics Inc. as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Axsome Therapeutics Inc. or others.